Literature DB >> 22581048

[Individualization of IOL constants for two hydrophobic intraocular lenses. SRK II, SRK/T, Hoffer-Q, Holladay 1 and Haigis formula].

A Langenbucher1, T Eppig, A Viestenz, B Seitz, G Müllner, U Schönherr.   

Abstract

AIM: The aim of the study was an assessment of refraction error after implantation of two types of hydrophobic acrylic intraocular lenses and derivation of customized IOL constants for the SRK II, SRK/T, Hoffer Q, Holladay 1 and Haigis formula.
PURPOSE: The purpose of the present study was to analyze the refractive outcome of two hydrophobic acrylic intraocular lenses and to present a computerized calculation scheme for customization of lens-specific parameters provided by the lens manufacturers based on the refractive results of a surgeon or study center.
METHODS: In this prospective monocentric study 100 consecutive cataract eyes were treated at the Eye Hospital of the Barmherzige Brüder (Compassionate Brothers) in Linz/Austria with a hydrophobic acrylic aspherical intraocular lens (Polytech Y10AS, n = 50) or a hydrophobic acrylic spherical intraocular lens (Hoya PC-60R, n = 50). The biometrical data were assessed preoperatively together with the refractive outcome 8-10 weeks after treatment in order to analyze the deviation of postoperative refraction (spherical equivalent) from target refraction (ΔREF) and to customize the lens constants for the SRK II, SRK/T, Hoffer Q, Holladay 1 and Haigis formula.
RESULTS: Based on this data set it could be demonstrated that using the lens constant provided by the manufacturer (ΔREF) the Polytech lens showed a systematic trend to myopia in contrast to the Hoya lens which ranged around zero. This trend could be compensated by selecting appropriate lens specific constants. For the Polytech/Hoya lens median lens constants of: A = 118.0/118.6 (SRK II), A = 117.9/118.6 (SRK/T), pACD = 4.8/5.1 (Hoffer Q), SF = 1.1/1.5 (Holladay I) and d = 4.2/4.6 (Haigis) were extracted and using linear regression a lens constant triplet for the Haigis formula of a(0) = 4.39, a(1) = 0.29, a(2) = 0.11/a0 = 4.73, a(1) = 0.30, a(2) = -0.01 could be derived.
CONCLUSIONS: Ophthalmic surgeons or surgical centers are encouraged to check (refractive) outcomes after cataract surgery permanently in terms of quality control. If a systematic trend in ΔREF could be extracted from the data set a customization of the lens-specific constants is recommended to eliminate systematic errors. Such customization is only valid for a dedicated environment (e.g. for one surgical center with standardized surgical techniques and measurement equipment) and cannot be generalized.

Entities:  

Mesh:

Year:  2012        PMID: 22581048     DOI: 10.1007/s00347-012-2535-x

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  18 in total

1.  [Comparison between ray-tracing and IOL calculation formulae of the 3rd generation].

Authors:  P-R Preussner; P Hoffmann; K Petermeier
Journal:  Klin Monbl Augenheilkd       Date:  2009-02-10       Impact factor: 0.700

2.  Intraocular lens power calculation with an improved anterior chamber depth prediction algorithm.

Authors:  T Olsen; L Corydon; H Gimbel
Journal:  J Cataract Refract Surg       Date:  1995-05       Impact factor: 3.351

3.  Standardizing constants for ultrasonic biometry, keratometry, and intraocular lens power calculations.

Authors:  J T Holladay
Journal:  J Cataract Refract Surg       Date:  1997-11       Impact factor: 3.351

4.  Development of the SRK/T intraocular lens implant power calculation formula.

Authors:  J A Retzlaff; D R Sanders; M C Kraff
Journal:  J Cataract Refract Surg       Date:  1990-05       Impact factor: 3.351

5.  Posterior chamber implant power calculation: regression formulas.

Authors:  J Retzlaff
Journal:  J Am Intraocul Implant Soc       Date:  1980-07

6.  A new intraocular lens calculation formula.

Authors:  J Retzlaff
Journal:  J Am Intraocul Implant Soc       Date:  1980-04

7.  Comparison of the SRK II formula and other second generation formulas.

Authors:  D R Sanders; J Retzlaff; M C Kraff
Journal:  J Cataract Refract Surg       Date:  1988-03       Impact factor: 3.351

8.  [Significance of optic formula selection for postoperative refraction after cataract operation].

Authors:  P C Hoffmann; W W Hütz; H B Eckhardt
Journal:  Klin Monbl Augenheilkd       Date:  1997-09       Impact factor: 0.700

Review 9.  [Calculation of pseudophakic toric intraocular lenses].

Authors:  T Eppig; A Viestenz; B Seitz; A Langenbucher
Journal:  Klin Monbl Augenheilkd       Date:  2011-04-06       Impact factor: 0.700

10.  Theoretical versus SRK I and SRK II calculation of intraocular lens power.

Authors:  T Olsen; K Thim; L Corydon
Journal:  J Cataract Refract Surg       Date:  1990-03       Impact factor: 3.351

View more
  5 in total

1.  Assessment of total corneal power after myopic corneal refractive surgery in Chinese eyes.

Authors:  Yanjun Hua; Chao Pan; Qinmei Wang
Journal:  Int Ophthalmol       Date:  2019-03-01       Impact factor: 2.031

2.  [Retroiridal implantation of a Verisyse™ iris claw lens: refractive outcome and individualized intraocular lens constants].

Authors:  I Schmidt; A Langenbucher; S Moussa; F Schirra; B Seitz; T Eppig
Journal:  Ophthalmologe       Date:  2015-03       Impact factor: 1.059

3.  IOL Formula Constants: Strategies for Optimization and Defining Standards for Presenting Data.

Authors:  Achim Langenbucher; Nóra Szentmáry; Alan Cayless; Michael Müller; Timo Eppig; Simon Schröder; Ekkehart Fabian
Journal:  Ophthalmic Res       Date:  2021-02-02       Impact factor: 2.892

4.  Personal A-constant in relation to axial length with various intraocular lenses.

Authors:  Mohamed A Eldaly; Khaled A Mansour
Journal:  Indian J Ophthalmol       Date:  2014-07       Impact factor: 1.848

5.  Determination of Personalized IOL-Constants for the Haigis Formula under Consideration of Measurement Precision.

Authors:  Simon Schröder; Christina Leydolt; Rupert Menapace; Timo Eppig; Achim Langenbucher
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.